# Huajin Capital

> Huajin Capital is a VC fund in Zhuhai backing Biotechnology and Biopharma. See 46 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Zhuhai, China
- Total investments: 46
- Last investment: Jun 2026
- Lead investor: 28%
- Last updated: Aug 2026
- Website: http://www.huajinct.com

Huajin Capital is a VC fund in Zhuhai focused on Biotechnology and Biopharma. Huajin Capital engages in equity investment, asset management, physical, and incubator.

## Contacts

5 contacts available for Huajin Capital. Shizune tracks 1 team members at Huajin Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/huajin-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 9 | 20% |
| Biopharma | 7 | 15% |
| Manufacturing | 7 | 15% |
| Medical | 6 | 13% |
| Health Care | 5 | 11% |

38 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 10 | 22% |
| Seed | 6 | 13% |
| Series B | 6 | 13% |
| Series C | 5 | 11% |
| Series D | 4 | 9% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 29 | 63% |
| United States | 4 | 9% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Liu Feihong | Managing Director | 3 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Dongsheng Fusion | Dongsheng Fusion is a magnetic confinement fusion technology company that develops miniaturized fusion power plant technology. | $100M | Seed | Jun 08, 2026 |  |
| Zhide New Energy | Zhide New Energy is a developer of high-capacity silicon anode materials for lithium batteries | $87.8M | Series E | Apr 09, 2026 |  |
| Zenitar | Baoling Bio is an innovative drug research and development and industrialization service provider. The company's research and development pipeline covers the research and development of innovative drugs such as tumors (solid tumors and hematomas), autoimmune diseases, and cytokine storms caused by new coronavirus pneumonia. | $86M | Series C | Jan 12, 2026 |  |
| GigaAI | Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space. | $28.3M | Series A | Dec 08, 2025 |  |
| HAAWKING | Haawking is a supplier of digital signal processors. Their products used in industrial control, motor drives, digital power supplies, photo voltaic, energy storage, new energy automotive and consumer electronics. Their customer can contact through mail id and phone number. |  | Series B | Jun 17, 2025 |  |
| HighlightLL Pharma | HighlightLL Pharma is a pharmaceutical company. | $20.5M | Series C | Jan 03, 2025 |  |
| SENASIC | SENASIC focuses on the development, design and sales of high-performance chips and sensors related to automotive and industrial IoT applications. SENASIC's main products include the automotive tire pressure sensor series, the MAP sensor series and the industrial-grade wireless temperature sensor series for the Internet of Things. SENASIC hasmany years of technical accumulation and autonomous IP in low-power MCU, high-precision ADC, low-frequency 125kHz interface, acceleration detection interface, RF transmission and other core functional modules. SENASIC has accumulated a lot of experience in chip packaging, testing, calibration and reliability technology to ensure the automotive quality of sensor products. The company's automotive tire pressure sensor has reached AEC-Q10 |  | Series D | Nov 26, 2024 |  |
| Huali Juneng | Huali Juneng is a pressure vessel and related equipment producer specializing in petroleum, chemical, oil, electricity, desalination, and medical. | $110.6M | Seed | Nov 18, 2024 |  |
| Bivision | Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment. | $13.8M | Series A | Jul 26, 2024 |  |
| Mellow Energy | Mellow Energy Technology is a new calcium ore photovoltaic cell enterprise. Its business is the research and development, production and sales of centralized and distributed photovoltaic power stations. |  | Seed | May 09, 2024 |  |

10 of 46 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 6 deals together
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 5 deals together
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 5 deals together
- Qiandao Fund — VC Fund, 5 deals together
- [Hengxu Capital](https://shizune.co/investors/profile/hengxu-capital) — VC Fund, 4 deals together
- Shang Qi Capital — VC Fund, 4 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Huajin Capital invest in?

Huajin Capital invests primarily in Biotechnology, Biopharma and Manufacturing startups, most often at Series A and Seed stage. Most of the 46 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Huajin Capital?

Public channels for Huajin Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Huajin Capital?

The team at Huajin Capital includes Liu Feihong (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co